Literature DB >> 9695391

Epidemiology of digestive tract cancers in India. III. Liver.

V Dhir1, K M Mohandas.   

Abstract

Liver cancer or hepatocellular carcinoma (HCC) is the fourth commonest cause of cancer deaths in the world. The condition is extremely common in Southeast Asia and Africa. In this report the available data on the epidemiology of HCC from India are summarized. We estimate that 12,750 new patients will be diagnosed to have HCC in India in the year 2001; this will comprise 1.6% of all incident cancers. Published studies from India and those involving Indian immigrants to other countries suggest that the prevalence of HCC is relatively lower in Indians than in most parts of the world. This contrasts with the widespread contamination of foods with aflatoxin and the moderately high prevalence of hepatitis B (HBV) and hepatitis C (HCV) virus-related chronic liver disease in India. There are no studies available to explain this observation. There are several articles on HBV and HCC in India but there is a paucity of analytical epidemiological data on HCV and HCC from India. Published studies indicate HBV to be the single most important etiologic association, with HCV playing a lesser but important role. About 80% of Indian patients with HCC have hepatitis virus-associated liver disease. Multicenter epidemiological studies are needed to solve some of the enigmas and observations peculiar to India.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9695391

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  9 in total

1.  Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse.

Authors:  Vineet Tyagi; Saroj K Singh; Ashu Sawhney; Vikas Taneja; Jacob M Puliyel
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 2.  Epidemiology of hepatocellular carcinoma in India.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2014-06-20

Review 3.  Risk factors for hepatocellular carcinoma in India.

Authors:  Premashis Kar
Journal:  J Clin Exp Hepatol       Date:  2014-04-13

4.  Impact of endoscopic ultrasound-guided fine-needle aspiration in prospective liver transplant recipients with hepatocellular carcinoma and lymphadenopathy.

Authors:  Narendra S Choudhary; Rajesh Puri; Sanjiv Saigal; Prashant Bhangui; Neeraj Saraf; Vinit Shah; Mukesh Nasa; Haimanti Sarin; Mridula Guleria; Randhir Sud; Arvinder S Soin
Journal:  Indian J Gastroenterol       Date:  2016-12-08

Review 5.  Th1/Th2 cytokines and their genotypes as predictors of hepatitis B virus related hepatocellular carcinoma.

Authors:  Roli Saxena; Jyotdeep Kaur
Journal:  World J Hepatol       Date:  2015-06-18

6.  Identification of Chromosomal Aberrations by Using Trypsin G-banding in Hepatocellular Carcinoma Patients (HCC) in Tamil Nadu, India.

Authors:  Subramaniam Mohana Devi; Vellingiri Balachandar; Palanivel Vel Murugan; Keshavarao Sasikala; Pappusamy Manikantan; Leela Krishnan Venkatakrishnan
Journal:  Trop Life Sci Res       Date:  2010-08

7.  Cancer incidence in the south Asian population of California, 1988-2000.

Authors:  Ratnali V Jain; Paul K Mills; Arti Parikh-Patel
Journal:  J Carcinog       Date:  2005-11-10

8.  Novel point and combo-mutations in the genome of hepatitis B virus-genotype D: characterization and impact on liver disease progression to hepatocellular carcinoma.

Authors:  Somenath Datta; Alip Ghosh; Debanjali Dasgupta; Amit Ghosh; Shrabasti Roychoudhury; Gaurav Roy; Soumyojit Das; Kausik Das; Subash Gupta; Keya Basu; Analabha Basu; Simanti Datta; Abhijit Chowdhury; Soma Banerjee
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

9.  Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience.

Authors:  Naveen Kalra; Mandeep Kang; Anmol Bhatia; Ajay K Duseja; Radha K Dhiman; Virendra K Arya; Arvind Rajwanshi; Yogesh K Chawla; Niranjan Khandelwal
Journal:  Indian J Radiol Imaging       Date:  2013-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.